The 3CL protease inhibitor is designed to suppress the replication of SARS-CoV-2, preventing COVID-19 illness, even if a household member is infected.
CROI - Conference of Retroviruses and Opportunistic Infections
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times - Pharmacy Practice News and Expert Insights
1
Subcutaneous Formulation of Guselkumab Receives FDA Approval in Ulcerative Colitis
2
FDA Grants Accelerated Approval to Elamipretide, First Treatment for Barth Syndrome
3
Confronting the Mental Health Crisis: Structural Inequities, Market Pressures, and the Role of Pharmacy Solutions
4
Teen Angst, Adolescent Anguish: Could It Be Mental Illness?
5
